Coronavirus Drug for Cats Has Potential Use for COVID-19 Virus in Humans

Researchers at the University of Alberta say a protease in SARS-CoV-2 can be targeted with a drug that is also used to treat feline infectious peritonitis, a fatal infection in cats caused by a coronavirus. The drugs, dipeptide-based protein inhibitors, could be used to slow or stop replication of the COVID-19 virus in humans. During the 70th annual meeting of the American Crystallographic Association, Joanne Lemieux will outline how the drugs are strong candidates for the treatment of human coronavirus infections.

Rutgers Expert Available to Discuss Risks of Ocean Activities During COVID-19 Pandemic

New Brunswick, N.J. (May 21, 2020) – Rutgers University–New Brunswick Professor Kay Bidle is available for interviews on the possible risks from the novel coronavirus or other pathogens while swimming or surfing in oceans, bays, lakes and rivers. “We currently know very…

Wichita State University chemist working to develop antiviral drugs in fight against COVID-19

Up until recently, COVID-19 (coronavirus disease 2019) may have been a relatively new phenomena to the general public, but Wichita State University medical chemist Bill Groutas, two virologists from Kansas State University, and a physician/virologist from the University of Iowa have been working on a cure for coronaviruses for more than three years.

‘There’s a history in North America of racism towards Asian communities during a disease outbreak,’ says @JohnsHopkins University professor Ho-Fung Hung #coronavirus

A sociology professor at Johns Hopkins University is available to discuss how the racist and xenophobic treatment of people of Chinese ancestry often escalates during outbreaks of disease such as the current coronavirus that began in China and is spreading…

Russian expert is ready to comment on the coronavirus

Pavel Volchkov heads the Genome Engineering Lab at the Moscow Institute of Physics and Technology (MIPT), that has several key projects, all of them involving genome editing mediated by the CRISPR/Cas technology. Discovered just a few years ago, CRISPR/Cas has…